{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:06:44Z","timestamp":1793848004237,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T00:00:00Z","timestamp":1350000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The histone H3K27 demethylases UTX and JMJD3 are important regulatory factors that modulate gene expression by altering the physical state of chromatin. Previous studies have indicated an abnormal H3K27 methylation status in carcinogenesis. We therefore investigated the expression patterns of UTX and JMJD3 in renal cell carcinoma (RCC) and their roles in cancer development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The mRNA expression levels of the <jats:italic>UTX<\/jats:italic> and <jats:italic>JMJD3<\/jats:italic> genes were determined in cancer tissues and adjacent normal tissues in 36 patients with primary RCC, using quantitative real-time-polymerase chain reaction. The UTX and JMJD3 protein contents were measured by western blotting and immunohistochemical analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              <jats:italic>UTX<\/jats:italic> and <jats:italic>JMJD3<\/jats:italic> transcripts were significantly increased in cancer tissues compared to normal tissues (P\u2009&lt;\u20090.05). mRNA levels of the inhibitor of cyclin-dependent kinases 4 and 6 <jats:italic>p16INK4a<\/jats:italic> were also increased in cancer tissues (P\u2009&lt;\u20090.001). Western blotting indicated that levels of both demethylases were increased in cancer tissues. The level of tri-methylated H3K27 (H3K27me3) was lower in cancer tissues compared to normal tissues, but expression of the H3K27 methyltransferase EZH2 was increased (P\u2009&lt;\u20090.05). These results suggest that the two H3K27 demethylases may play critical roles in the regulation of H3K27 methylation status in RCC. Immunohistochemical analysis confirmed that UTX and JMJD3 expression were upregulated in cancer tissues compared to adjacent tissues.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study demonstrated that UTX and JMJD3 were upregulated in cancer tissues, suggesting that they may be involved in the development of primary RCC. The potential roles of H3K27 demethylases as biomarkers in the early diagnosis of RCC need to be further explored.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-12-470","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T14:11:51Z","timestamp":1351692711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Expression and significance of histone H3K27 demethylases in renal cell carcinoma"],"prefix":"10.1186","volume":"12","author":[{"given":"Yongqing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,12]]},"reference":[{"key":"3494_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B: Renal cell carcinoma. Lancet. 2009, 373: 1119-1132. 10.1016\/S0140-6736(09)60229-4.","journal-title":"Lancet"},{"key":"3494_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1586\/era.09.43","volume":"9","author":"A Giubellino","year":"2009","unstructured":"Giubellino A, Linehan WM, Bottaro DP: Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther. 2009, 9: 785-793. 10.1586\/era.09.43.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3494_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007, 18: 581-592.","journal-title":"Ann Oncol"},{"key":"3494_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11523-010-0149-2","volume":"5","author":"B Basu","year":"2010","unstructured":"Basu B, Eisen T: Perspectives in drug development for metastatic renal cell cancer. Target Oncol. 2010, 5: 139-156. 10.1007\/s11523-010-0149-2.","journal-title":"Target Oncol"},{"key":"3494_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12094-010-0461-4","volume":"12","author":"C Su\u00e1rez","year":"2010","unstructured":"Su\u00e1rez C, Morales R, Mu\u00f1oz E, Rod\u00f3n J, Valverde CM, Carles J: Molecular basis for the treatment of renal cell carcinoma. Clin Transl Oncol. 2010, 12: 15-21. 10.1007\/s12094-010-0461-4.","journal-title":"Clin Transl Oncol"},{"key":"3494_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4161\/cbt.10.7.13247","volume":"10","author":"G Banumathy","year":"2010","unstructured":"Banumathy G, Cairns P: Signaling pathways in renal cell carcinoma. Cancer Biol Ther. 2010, 10: 658-864. 10.4161\/cbt.10.7.13247.","journal-title":"Cancer Biol Ther"},{"key":"3494_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/14737159.9.1.75","volume":"9","author":"A Mohammed","year":"2009","unstructured":"Mohammed A, Shergill I, Little B: Management of metastatic renal cell carcinoma: current trends. Expert Rev Mol Diagn. 2009, 9: 75-83. 10.1586\/14737159.9.1.75.","journal-title":"Expert Rev Mol Diagn"},{"key":"3494_CR8","first-page":"1","volume":"8","author":"AI Chin","year":"2006","unstructured":"Chin AI, Lam JS, Figlin RA, Belldegrun AS: Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006, 8: 1-7.","journal-title":"Rev Urol"},{"key":"3494_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.eururo.2009.01.003","volume":"55","author":"C Eichelberg","year":"2009","unstructured":"Eichelberg C, Junker K, Ljungberg B, Moch H: Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol. 2009, 55: 851-863. 10.1016\/j.eururo.2009.01.003.","journal-title":"Eur Urol"},{"key":"3494_CR10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00018-010-0624-z","volume":"68","author":"M Hatziapostolou","year":"2011","unstructured":"Hatziapostolou M, Iliopoulos D: Epigenetic aberrations during oncogenesis. Cell Mol Life Sci. 2011, 68: 1681-1702. 10.1007\/s00018-010-0624-z.","journal-title":"Cell Mol Life Sci"},{"key":"3494_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi P, Allis CD, Wang GG: Covalent histone modifications\u2013miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer. 2010, 10: 457-469. 10.1038\/nrc2876.","journal-title":"Nat Rev Cancer"},{"key":"3494_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1101\/sqb.2010.75.020","volume":"75","author":"MR H\u00fcbner","year":"2010","unstructured":"H\u00fcbner MR, Spector DL: Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harb Symp Quant Biol. 2010, 75: 43-49.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"3494_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","volume":"647","author":"JA Simon","year":"2008","unstructured":"Simon JA, Lange CA: Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res. 2008, 647: 21-29. 10.1016\/j.mrfmmm.2008.07.010.","journal-title":"Mutat Res"},{"key":"3494_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/1471-2407-10-524","volume":"10","author":"N Wagener","year":"2010","unstructured":"Wagener N, Macher-Goeppinger S, Pritsch M, H\u00fcsing J, Hoppe-Seyler K, Schirmacher P, Pfitzenmaier J, Haferkamp A, Hoppe-Seyler F, Hohenfellner M: Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC Cancer. 2010, 10: 524-10.1186\/1471-2407-10-524.","journal-title":"BMC Cancer"},{"key":"3494_CR15","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1016\/j.juro.2009.08.014","volume":"182","author":"S Hinz","year":"2009","unstructured":"Hinz S, Weikert S, Magheli A, Hoffmann M, Engers R, Miller K, Kempkensteffen C: Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma. J Urol. 2009, 182: 2920-2925. 10.1016\/j.juro.2009.08.014.","journal-title":"J Urol"},{"key":"3494_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2007.09.026","volume":"131","author":"T Swigut","year":"2007","unstructured":"Swigut T, Wysocka J: H3K27 demethylases, at long last. Cell. 2007, 131: 29-32. 10.1016\/j.cell.2007.09.026.","journal-title":"Cell"},{"key":"3494_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, Issaeva I, Canaani E, Salcini AE, Helin K: UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007, 449: 731-7314. 10.1038\/nature06145.","journal-title":"Nature"},{"key":"3494_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.1149042","volume":"318","author":"MG Lee","year":"2007","unstructured":"Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D, Di Croce L, Shiekhattar R: Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science. 2007, 318: 447-450. 10.1126\/science.1149042.","journal-title":"Science"},{"key":"3494_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature06192","volume":"449","author":"F Lan","year":"2007","unstructured":"Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E, Roberts TM, Chang HY, Shi Y: A histone H3 lysine 27 demethylase regulates animal posterior development. Nature. 2007, 449: 689-694. 10.1038\/nature06192.","journal-title":"Nature"},{"key":"3494_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/cr.2007.83","volume":"17","author":"Y Xiang","year":"2007","unstructured":"Xiang Y, Zhu Z, Han G, Lin H, Xu L, Chen CD: JMJD3 is a histone H3K27 demethylase. Cell Res. 2007, 17: 850-857. 10.1038\/cr.2007.83.","journal-title":"Cell Res"},{"key":"3494_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ng.349","volume":"41","author":"G van Haaften","year":"2009","unstructured":"van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O\u2019Meara S, Teague J, Butler A, Hinton J, Latimer C, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Cole J, Forbes S, Jia M, Jones D, Kok CY, Leroy C, Lin ML, McBride DJ, Maddison M, Maquire S, McLay K, Menzies A, Mironenko T, Mulderrig L, Mudie L, Pleasance E, Shepherd R, Smith R, Stebbings L, Stephens P, Tang G, Tarpey PS, Turner R, Turrell K, Varian J, West S, Widaa S, Wray P, Collins VP, Ichimura K, Law S, Wong J, Yuen ST, Leung SY, Tonon G, DePinho RA, Tai YT, Anderson KC, Kahnoski RJ, Massie A, Khoo SK, Teh BT, Stratton MR, Futreal PA: Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet. 2009, 41: 521-523. 10.1038\/ng.349.","journal-title":"Nat Genet"},{"key":"3494_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","volume":"6","author":"SA Fuhrman","year":"1982","unstructured":"Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982, 6: 655-663. 10.1097\/00000478-198210000-00007.","journal-title":"Am J Surg Pathol"},{"key":"3494_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/1471-2407-11-413","volume":"11","author":"S Wu","year":"2011","unstructured":"Wu S, Wang Y, Sun L, Zhang Z, Jiang Z, Qin Z, Han H, Liu Z, Li X, Tang A, Gui Y, Cai Z, Zhou F: Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma. BMC Cancer. 2011, 11: 413-10.1186\/1471-2407-11-413.","journal-title":"BMC Cancer"},{"key":"3494_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0065-230X(09)02004-1","volume":"102","author":"SC Kampranis","year":"2009","unstructured":"Kampranis SC, Tsichlis PN: Histone demethylases and cancer. Adv Cancer Res. 2009, 102: 103-169.","journal-title":"Adv Cancer Res"},{"key":"3494_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4149\/neo_2011_02_153","volume":"58","author":"X Guo","year":"2011","unstructured":"Guo X, Shi M, Sun L, Wang Y, Gui Y, Cai Z, Duan X: The expression of histone demethylase JMJD1A in renal cell carcinoma. Neoplasma. 2011, 58: 153-157. 10.4149\/neo_2011_02_153.","journal-title":"Neoplasma"},{"key":"3494_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1128\/MCB.00444-09","volume":"30","author":"AJ Krieg","year":"2010","unstructured":"Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S, Giaccia AJ: Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol. 2010, 30: 344-353. 10.1128\/MCB.00444-09.","journal-title":"Mol Cell Biol"},{"key":"3494_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1101\/gad.510809","volume":"23","author":"K Agger","year":"2009","unstructured":"Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, Helin K: The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 2009, 23: 1171-1176. 10.1101\/gad.510809.","journal-title":"Genes Dev"},{"key":"3494_CR28","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.4161\/cc.9.11.11845","volume":"9","author":"MC Tsai","year":"2010","unstructured":"Tsai MC, Wang JK, Chang HY: Tumor suppression by the histone demethylase UTX. Cell Cycle. 2010, 9: 2043-2044. 10.4161\/cc.9.11.11845.","journal-title":"Cell Cycle"},{"key":"3494_CR29","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1101\/gad.511109","volume":"23","author":"M Barradas","year":"2009","unstructured":"Barradas M, Anderton E, Acosta JC, Li S, Banito A, Rodriguez-Niedenf\u00fchr M, Maertens G, Banck M, Zhou MM, Walsh MJ, Peters G, Gil J: Histone demethylase JMJD3 contributes to epigenetic control of INK4a\/ARF by oncogenic RAS. Genes Dev. 2009, 23: 1177-1182. 10.1101\/gad.511109.","journal-title":"Genes Dev"},{"key":"3494_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrc1073","volume":"3","author":"J Campisi","year":"2003","unstructured":"Campisi J: Cancer and ageing: rival demons?. Nat Rev Cancer. 2003, 3: 339-349. 10.1038\/nrc1073.","journal-title":"Nat Rev Cancer"},{"key":"3494_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrm1987","volume":"7","author":"J Gil","year":"2006","unstructured":"Gil J, Peters G: Regulation of the INK4b\u2013ARF\u2013INK4a tumour suppressor locus: All for one or one for all. Nat Rev Mol Cell Biol. 2006, 7: 667-677.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3494_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrc1884","volume":"6","author":"M Collado","year":"2006","unstructured":"Collado M, Serrano M: The power and the promise of oncogene induced senescence markers. Nat Rev Cancer. 2006, 6: 472-476. 10.1038\/nrc1884.","journal-title":"Nat Rev Cancer"},{"key":"3494_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi J, D\u2019Adda Di Fagagna F: Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol. 2007, 8: 729-740.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3494_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/epi.5.8.12996","volume":"5","author":"N Popov","year":"2010","unstructured":"Popov N, Gil J: Epigenetic regulation of the INK4b-ARF-INK4a locus: In sickness and in health. Epigenetics. 2010, 5: 685-690. 10.4161\/epi.5.8.12996.","journal-title":"Epigenetics"},{"key":"3494_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1101\/gad.1499407","volume":"21","author":"Y Kotake","year":"2007","unstructured":"Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y: pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev. 2007, 21: 49-54. 10.1101\/gad.1499407.","journal-title":"Genes Dev"},{"key":"3494_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1101\/gad.415507","volume":"21","author":"AP Bracken","year":"2007","unstructured":"Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-M\u00f6nch K, Minucci S, Porse BT, Marine JC, Hansen KH, Helin K: The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 2007, 21: 525-530. 10.1101\/gad.415507.","journal-title":"Genes Dev"},{"key":"3494_CR37","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/onc.2010.579","volume":"30","author":"JA Anderton","year":"2011","unstructured":"Anderton JA, Bose S, Vockerodt M, Vrzalikova K, Wei W, Kuo M, Helin K, Christensen J, Rowe M, Murray PG, Woodman CB: The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin\u2019s Lymphoma. Oncogene. 2011, 30: 2037-2043. 10.1038\/onc.2010.579.","journal-title":"Oncogene"},{"key":"3494_CR38","first-page":"4299","volume":"26","author":"T Kasahara","year":"2006","unstructured":"Kasahara T, Bilim V, Hara N, Takahashi K, Tomita Y: Homozygous deletions of the INK4a\/ARF locus in renal cell cancer. Anticancer Res. 2006, 26: 4299-4305.","journal-title":"Anticancer Res"},{"key":"3494_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1101\/gad.1882610","volume":"24","author":"JK Wang","year":"2010","unstructured":"Wang JK, Tsai MC, Poulin G, Adler AS, Chen S, Liu H, Shi Y, Chang HY: The histone demethylase UTX enables RB-dependent cell fate control. Genes Dev. 2010, 24: 327-332. 10.1101\/gad.1882610.","journal-title":"Genes Dev"},{"key":"3494_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbrc.2010.07.061","volume":"399","author":"M Terashima","year":"2010","unstructured":"Terashima M, Ishimura A, Yoshida M, Suzuki Y, Sugano S, Suzuki T: The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase. Biochem Biophys Res Commun. 2010, 399: 238-244. 10.1016\/j.bbrc.2010.07.061.","journal-title":"Biochem Biophys Res Commun"},{"key":"3494_CR41","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1128\/MCB.01633-09","volume":"30","author":"HM Herz","year":"2010","unstructured":"Herz HM, Madden LD, Chen Z, Bolduc C, Buff E, Gupta R, Davuluri R, Shilatifard A, Hariharan IK, Bergmann A: The H3K27me3 demethylase dUTX is a suppressor of Notch- and Rb-dependent tumors in Drosophila. Mol Cell Biol. 2010, 30: 2485-2497. 10.1128\/MCB.01633-09.","journal-title":"Mol Cell Biol"},{"key":"3494_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1471-2407-9-461","volume":"9","author":"LR He","year":"2009","unstructured":"He LR, Liu MZ, Li BK, Rao HL, Liao YJ, Guan XY, Zeng YX, Xie D: Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma. BMC Cancer. 2009, 9: 461-10.1186\/1471-2407-9-461.","journal-title":"BMC Cancer"},{"key":"3494_CR43","first-page":"75","volume":"1815","author":"RA Varier","year":"2011","unstructured":"Varier RA, Timmers HT: Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta. 2011, 1815: 75-89.","journal-title":"Biochim Biophys Acta"},{"key":"3494_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/1947601911417976","volume":"2","author":"D Rotili","year":"2011","unstructured":"Rotili D, Mai A: Targeting histone demethylases: a new avenue for the fight against cancer. Genes Cancer. 2011, 2: 663-679. 10.1177\/1947601911417976.","journal-title":"Genes Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-470\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:55:14Z","timestamp":1630616114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3494"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-470","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,12]]},"assertion":[{"value":"31 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"470"}}